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Abstract
The pathogenesis of persistent viral infections depends critically on long-term viral loads. Yet what determines these loads is
largely unknown. Here, we show that a single CD8
+ T cell epitope sets the long-term latent load of a lymphotropic gamma-
herpesvirus, Murid herpesvirus-4 (MuHV-4). The MuHV-4 M2 latency gene contains an H2-K
d -restricted T cell epitope, and
wild-type but not M2
2 MuHV-4 was limited to very low level persistence in H2
d mice. Mutating the epitope anchor residues
increased viral loads and re-introducing the epitope reduced them again. Like the Kaposi’s sarcoma–associated herpesvirus
K1, M2 shows a high frequency of non-synonymous mutations, suggesting that it has been selected for epitope loss. In vivo
competition experiments demonstrated directly that epitope presentation has a major impact on viral fitness. Thus, host
MHC class I and viral epitope expression interact to set the long-term virus load.
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Introduction
Gamma-herpesviruses characteristically persist in lymphocytes.
Since the pool of latent genomes is constantly drained by viral
reactivation, it must be replenished by virus-driven lymphoprolif-
eration; this in turn is limited by host T cells; the steady-state viral
load reflects an equilibrium of these fluxes. Viral loads are
remarkably constant in one individual, yet vary hugely between
them [1]. What determines the set point? Such questions are
difficult to address without animal models. Murid herpesvirus-4
(MuHV-4) is one of the best established. It is genetically closer to
Kaposi’s sarcoma associated herpesvirus (KSHV) than to Epstein-
Barr virus (EBV), but shares with EBV a lymphoproliferative
infectious mononucleosis syndrome [2] and persistence in memory
B cells [3–5]. The pathogenesis of KSHV infection is presumably
similar. The steady state MuHV-4 latent load does not appear to
reflect the inoculating virus dose [6], suggesting that it is set instead
by host and viral genetic polymorphisms.
Both host immunity and viral evasion contribute to MuHV-4
pathogenesis. Evasion dominates during acute latency amplification.
The MuHV-4 K3 protein promotes this [7] by degrading MHC class
I heavy chains and TAP [8,9]. K3 is transcribed in latently infected
germinal centre B cells [7], but also functions in lytically infected
myeloid cells [10,11], which are present in lymphoid tissue [4] and
are probably an important source of the viral M3 chemokine binding
protein [12,13]. The quantitative contribution of M3 to CD8
+ Tc e l l
evasion remains controversial [14,15]. However, it is clearly capable
of such a role [16]. M4 is another secreted lytic gene product that
promotes latency amplification [17,18]. Thus, K3 may act both
directly and by allowing lytically infected cells to protect latently
infected cells in trans [19]. The MuHV-4 ORF73 episome
maintenance protein has a further cis-acting CD8
+ Tc e l le v a s i o n
mechanism, equivalent to that of EBV EBNA-1 [20,21], that is again
vital for host colonization [22].
Despite immune evasion, virus-driven lymphoproliferation is
brought under control by 3–4 weeks post-infection, at least in part
by CD8
+ T cells [23–25]. H2
d mice mount a CD8
+ T cell response
against the M2 latency gene product at this time [26]. EBV latent
loads and associated pathologies are similarly controlled by CD8
+
T cells that recognize viral latent antigens [27,28]. EBNA-1-
specific CD4
+ T cells can also suppress EBV lymphoproliferation
in vitro [29,30], but whether equivalent recognition occurs in vivo is
unclear [31]: even optimized latent CD4
+ T cell epitope
expression has little effect on MuHV-4 host colonization [32].
Most evidence would therefore suggest that gamma-herpesvirus
latency is controlled principally by latent antigen-specific CD8
+ T
cells [27,28]. Vaccination with the M2 latency epitope has little
effect on MuHV-4 latency establishment [33] because viral
evasion dominates this setting. However, the impact of M2
recognition on the steady state viral load has not been defined.
The balance of immunity and evasion could be subtly different
here, for example if M3 function is now blocked by antibody.
M2 itself promotes acute latency amplification [34–36] by
modulating Vav-dependent B cell signaling [37,38]. The EBV
LMP-2A [39,40] and KSHV K1 [41,42] have equivalent roles. M2
also has anti-interferon and anti-apoptotic functions [43,44],
although what these contribute to latency is unclear. An unusual
feature of the M2 knockout phenotype in BALB/c (H2
d)m i c ei st h a t
despite an acute latency deficit, long-term latency is increased [36].
C57BL/6 mice (H2
b), which are not known to recognize an M2
epitope, show the same acute latency deficit, but not the long-term
increase [34]. Here we show that although M2 itself promotes acute
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d-restricted CD8
+ T cell epitope is a
major negative determinant of the long-term viral load. The
reduction in latency associated with M2 expression required both
its CD8
+ T cell epitope and an appropriate host restriction element.
Thus, host MHC class I polymorphisms interact with viral latency
gene expression to determine the steady state gamma-herpesvirus
load.
Results
Long-term latency depends on viral M2 expression and
host H2 haplotype
Our starting point were the observations that MuHV-4 M2
knockouts show an acute latency deficit in both BALB/c and
C57BL/6 mice, but an elevated long-term latent load only in
BALB/c mice [34,36]; and that mutating only the M2 amino acid
residues critical for its interactions with Vav and Fyn [37,38]
reproduces the acute latency deficit but not the long-term increase
[37]. We hypothesized that a lack of H-2K
d-restricted epitope
presentation might contribute significantly to the M2 knockout
phenotype. We tested this further by comparing M2
2 (vM2FS; a
previously described M2 frame shift mutant [36]) and M2
+ (vWT)
viral loads in different H2
d and non-H2
d mice (Figure 1).
At 14 days post-infection, both H2
d and non-H2
d mice showed
an M2-dependent latency deficit, consistent with M2 having an
important role in acute latency amplification, when viral evasion
limits CD8
+ T cell function [7,14,22]. But by 50 days post-
infection, when reactivatable wild-type virus was barely detectable
in BALB/c mice (H2
d), M2
2 virus titres were maintained and now
exceeded those of the wild-type. In contrast, long-term vWT titres
in C57BL/6 mice (H2
b) were equivalent to those of the M2
mutant; DBA/2 mice (H2
d) were similar to BALB/c; FVB-N
(H2
q) were similar to C57BL/6; and B6.C mice, where the H2
d
locus has been backcrossed onto a C57BL/6 background, were
similar to BALB/c. M2 expression therefore increased the acute
latent load independent of H2 type and reduced the long-term
latent load in an H2-restricted manner: low long-term latency
levels correlated with the H2
d haplotype.
Generation of M2 mutant viruses with altered H-2K
d
epitopes
Residues 84–92 of M2 contain its H-2K
d-restricted T cell
epitope, GFNKLRSTL [26]. We tested whether the recognition of
this epitope could explain the H2-restricted difference in long-term
M2
2/M2
+ latent loads by mutating its anchor residues to alanines,
either the phenylalanine at position 85 (vM2F85A) or the leucine at
position 92 (vM2L92A). We reverted the vM2F85A mutant in two
ways: first conventionally, by restoring position 85 to phenylala-
nine (vM2F85AR), and second by re-introducing the
GFNKLRSTL epitope ectopically at the M2 C-terminus
(vM2F85AEPI). All these viruses showed an otherwise intact M2
locus, normal in vitro growth and normal replication in infected
lungs (Figure 2A–C). Intracellular IFN-c staining of CD8
+ T cells
from infected mice (Figure 2D) showed that either anchor residue
mutation prevented the generation of H-2K
d-GFNKLRSTL-
specific CD8
+ T cells, and that re-introducing the epitope into its
ectopic site restored the response.
Long-term latent loads of M284–92 anchor residue
mutants
The acute (d14) latency titres of the anchor residue mutants in
BALB/c mice were indistinguishable from the wild-type (Figure 3).
Thus, there was no evidence that the point mutations affected M2
function. This was consistent with neither residue 85 nor residue
92 being crucial for the M2 Vav/Fyn interaction [37,38]. The C-
terminal GFNKLRSTL epitope insertion also had no appreciable
impact on latency establishment. At d14 post-infection, the impact
of epitope presentation is limited by viral evasion. But in contrast
to these normal acute titres, the long-term titres of the anchor
residue mutants were increased, like those of the vM2FS mutant,
while those of the vM2F85AR, vM2F85AEPI viruses were low, like
those of the wild-type. Thus, the presence of a presentable epitope
in M2 had a major impact on the long-term viral load.
Lower latency loads due to M284–92 epitope expression
are CD8
+ T cell linked
The increase in long-term viral load following CD8
+ T cell
epitope disruption implied that CD8
+ T cell function helps to set
this load in BALB/c mice. To confirm this, we depleted CD8
+ T
cells from vWT infected BALB/c mice by injection of anti-CD8
monoclonal antibody (MAb). Importantly, depletion was initiated
at 11 days post-infection, which is after the resolution of lytic
infection but prior to the peak H-2K
d-GFNKLRSTL-specific
CD8
+ T cell response. The last MAb injection was performed at
d19. Latent loads were analysed at d21 post-infection (Figure 4).
The variability in titer between depleted mice probably reflected
incomplete depletion, as post-infection depletions are often less
efficient than pre-infection (our unpublished data), and the efficacy
of depletion in individual mice infected with vWT or vM2F85AEPI
correlated with viral load. Nevertheless, mice infected with the
anchor residue mutants had significantly higher splenic latent
loads than mice infected with epitope-expressing viruses before
depletion, and not after CD8
+ T cell depletion. CD8
+ T cells were
therefore responsible for the low latent loads of vWT and
vM2F85AEPI.
Increased germinal centre B cell colonization by MuHV-4
lacking M284–92 epitope anchor residues
In situ hybridization for viral tRNA expression, a marker of
lymphoid colonization [45,46] (Figure 5A–B), showed similar
results to the explant co-culture assays. Thus, the wild-type signal
was high acutely (d14) but low long-term; the vM2FS mutant had
a low acute signal but was higher at later times; the anchor residue
mutants had high signals both acutely and long-term; and re-
introducing the GFNKLRSTL epitope reduced the long-term
signal back to wild-type levels. The vM2F85A and vM2L92A
Author Summary
Persistent viruses present a major challenge to the
immune response. Gamma-herpesviruses are a prime
example, and the archetypal family member, Epstein-Barr
virus (EBV), has been studied for many years. A major
unanswered question with EBV is why long-term virus
loads—a key pathogenesis outcome—vary so widely
between individuals. As most EBV studies are necessarily
descriptive, the murid gamma-herpesvirus MuHV-4 pro-
vides an important focus of pathogenesis research. Here,
we used MuHV-4 to address what determines long-term
gamma-herpesvirus loads. We find a major role for a single
MHC class I–restricted latency epitope. This reflects that
latency-associated viral immune evasion and transcription-
al silencing create a unique setting, in which the pool of
possible epitopes is small enough for epitope loss to have
a significant impact on viral fitness. Our data suggest that
polymorphisms in viral latency genes and in host HLA class
I together determine long-term viral loads.
CD8
+ T Cell Epitope Sets Latent Load
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+ germinal centres (Figure 5B)
and bigger viral tRNA
+ germinal centres (Figure 5A), consistent
with the idea that disrupting CD8
+ T cell recognition of M2
allowed more extensive proliferation of latently infected B cells.
We have previously correlated the higher long-term latent loads
of M2
2 MuHV-4 in BALB/c mice with increased frequencies of
viral genome
+ germinal centre B cells [36]. We tested whether this
applied also to the anchor residue mutants by subjecting flow
cytometrically sorted germinal centre B cells to limiting dilution,
PCR-based viral genome detection (Figure 5C). The frequency of
viral genome
+ B cells was higher for the wild-type than for the
vM2FS mutant at 14 days post-infection, and lower at 50 days
post-infection; the vM2F85A and vM2L92A mutants showed high
frequencies of viral genome
+ B cells at both time points; and the
vM2F85AR (data not shown) and vM2F85AEPI revertants were
similar to the wild-type. Moreover, even at 133 days post-infection
1 in 19 GC B cells carried M2F85A DNA. At this time the
frequency of M2F85AR DNA
+ GC B cells was 1 in 5274. Thus, the
colonization of germinal centre B cells matched the total viral load
in the spleen, with early colonization depending on M2 function
and late colonization depending on T cell epitope presentation.
Evidence for M2 positive selection
M2 is positionally homologous to the KSHV K1. In so far as
both modulate B cell antigen receptor signalling [37,38,41,42],
they are also functionally homologous. Thus, it might be expected
that MuHV-4 and KSHV share a latency program where M2 or
K1 accounts for much of the presentable latent antigen. There is
indirect evidence that this matters for K1: DNA sequence
comparison between KSHV strains suggests that K1 has been
positively selected for amino acid diversity [47]. A comparison of
MuHV-4 with a closely related herpesvirus recovered from a
shrew [48] shows the same phenomenon: M1, M3, M4 and ORF4
have non-synonymous to synonymous mutation ratios of 0.20–
0.27, while M2 has a ratio of 1.01 (Andrew Davison, personal
communication).
In order to gain more direct evidence for M2 immune selection,
we co-infected BALB/c mice with epitope
+ and epitope
2 viruses,
Figure 1. Long-term MuHV-4 latent loads depend on viral M2 expression and host H2 haplotype. Mice were infected intranasally with
wild-type (vWT) or M2
2 (vM2FS) viruses. At d14 or d50 post-infection spleens were removed and titrated for reactivation-competent virus by explant
co-culture with BHK-21 cells. Each point shows the titre of one mouse. The horizontal bars show arithmetic means. The dashed horizontal line
represents the limit of assay detection. Pre-formed infectious virus, as measured by the parallel titration of equivalent frozen/thawed samples, was
below the limit of assay detection. At d50 post-infection the vM2FS latent load was significantly higher than the vWT latent load in BALB/c (P=0.011)
and DBA/2 (P=3610
25) and close to significance in B6.C.H2
d (P=0.056), but not in C57BL/6 (P=0.228) and FVB-N (P=0.347) by a one-tailed
Student’s t-Test. This was also confirmed by combining all data from H2
d mouse strains (P,0.0001) but not from non-H2
d mice (P=0.71) using a 2-
way non-parametric ANOVA Friedman’s test. Data were reproducible over two independent experimental groups.
doi:10.1371/journal.ppat.1000177.g001
CD8
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PLoS Pathogens | www.plospathogens.org 3 October 2008 | Volume 4 | Issue 10 | e1000177Figure 2. MuHV-4 latent epitope mutants show normal in vitro and in vivo replication. A. High molecular weight DNA from MuHV-4-
infected BHK-21 cells was checked by PCR for genome integrity in the HinDIII-E region. A schematic representation of the MuHV-4 genome and
amplicon coordinates for each PCR is shown. B. BHK-21 cells were infected (0.01 PFU per cell) with the indicated viruses, washed in PBS and virus
replication with time was monitored by plaque assay. C. BALB/c mice were intranasally infected with 10
4 PFU of the indicated viruses. At the
indicated days post-infection lungs were removed and titrated for infectious virus by plaque assay. Each point represents the titre of an individual
mouse. Horizontal lines indicate arithmetic means. None of the mutants showed a deficit relative to the wild-type (p.0.5 by 1-way non-parametric
ANOVA Kruskal-Wallis Test). D. Splenocytes of BALB/c mice infected with viruses of the indicated genotypes were stimulated in vitro with either
M284–92 (black bars) or EGFP200–208 as a control (white bars) in the presence of Brefeldin A, then stained for intracellular interferon-gamma. The data
show the percentage of CD8
+ T cells responding to peptide at each time point (arithmetic means6SEMs from 3 independent measurements). *,
p,0.05 using a 1 tailed Student’s t-test.
doi:10.1371/journal.ppat.1000177.g002
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centre B cells using virus-specific primers (Figure 6). For co-
infection experiments, aliquots of the same viral preparations were
used to formulate viral mixes that contained equal amounts of
infectious units of each virus of interest, i.e. 5610
3 PFU of each
viral genotype, as determined by plaque assay. At d14 post-
infection, there was little difference between vWT and vM2F85A,
but by d50 vM2F85A accounted for .95% of the viral genomes.
vM2F85AEPI and vM2F85A gave a similar result, the proportion of
vM2F85A genomes increasing with time, while mixed vM2F85A and
vM2L92A loads remained equivalent. Thus, viruses lacking M2
epitope presentation contributed disproportionately to long-term
host colonization in BALB/c mice. The advantage of epitope null
viruses over vWT was H2
d-dependent, since it was not observed in
Figure 3. The presence of a CD8
+ T cell epitope in M2 sets the MuHV-4 long-term latent load. BALB/c mice were intranasally infected (10
4
PFU) and at 14, 21, 50 or 80 days post-infection spleen removed and titrated for reactivation-competent virus by explant co-culture. Each point shows
the titre of one mouse. Horizontal lines indicate arithmetic means. The dashed horizontal line represents the limit of assay detection. Pre-formed
infectious virus, as measured by parallel titration of equivalent frozen/thawed samples, was below the limit of detection of the assay. At d50 and d80
post-infection vM2F85A and vM2L92A showed significantly higher latency loads than vWT: d50, vM2F85A p=0.021, vM2L92A p=0.012; d80, vM2F85A
p=0.007, vM2L92A p=0.001; using 1 tailed Student’s t-Test with p values shown when false discovery rate correction for multiple testing (FDR) was
,0.05. Data were reproducible over two independent experimental groups.
doi:10.1371/journal.ppat.1000177.g003
CD8
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accounted for the majority of MuHV-4 genomes at all times.
Discussion
Gamma-herpesvirus infections encompass complex combina-
tions of cell types, anatomical sites, viral gene expression patterns
and immune effector functions. This has made elusive a
comprehensive understanding of how host immunity and viral
evasion interact. Nevertheless, a consensus picture is now
emerging. The long-term latent viral load is a key outcome, since
it correlates with virus shedding [1] and probably also with disease.
Maintained episomes replicate in step with normal cell division
[49]. However, compensating for reactivation-associated latent
genome loss requires a more complex program of virus-driven
lymphoproliferation. This opens up another front between host
immunity and viral evasion.
Lytic reactivation could itself potentially re-seed latency, and
this seems to be important in B cell-deficient mice [50]. However,
these mice lack both the major MuHV-4 latency reservoir and
virus-specific antibody, and consequently have an infection quite
different to that of wild-type mice. The severe latency deficiency of
viruses lacking episome maintenance [51,52] argues that as with
EBV [53], MuHV-4 persistence in immunocompetent hosts
depends on lymphoproliferation. The efficiency with which
proliferating B cells present CD8
+ T cell targets must therefore
also be important. The protection of B cells expressing M2 by K3
is probably only partial. The data presented here show that the
impact of CD8
+ T cell immunity can depend on a single epitope,
consistent with epidemiological evidence of epitope selection in the
EBV EBNA-3 [54,55] and the KSHV K1 [47].
The importance of a single latency epitope for MuHV-4
contrasts with lymphocytic choriomeningitis virus infection, where
removing an immunodominant CD8
+ T cell target simply brings
out subdominant epitopes [56]. This may reflect that lymphocytic
choriomeningitis virus does not suppress MHC class I-restricted
antigen presentation, making the pool of possible epitopes larger.
C57BL/6 mice illustrate what can happen when classical CD8
+ T
cell recognition of a key MuHV-4 target fails. Rather than overt
disease, a back-up mechanism of non-classical Vb4
+CD8
+ T cell
recognition comes into play [17,57]. The higher latent loads of
C57BL/6 mice despite massive CD8
+Vb4
+ T cell expansion
suggest this mechanism is not particularly efficient, and in C57BL/
6 mice infected with K3-deficient MuHV-4 [7] or in BALB/c
mice infected with the wild-type [17] CD8
+Vb4
+ T cell expansion
is minimal, presumably because classical recognition takes over.
However, non-classical recognition appears to provide a safety net
when host genetics or viral evasion limit normal antigen
presentation.
Unlike the fairly consistent and predictable effects of an attack
on the cellular antigen presentation machinery or a silencing of
viral transcription/translation, the interaction between viral
epitope loss and host MHC class I diversity creates unstable and
hard-to-predict outcomes. For example, the most pathogenic virus
variant may be quite different between different out-bred hosts.
Epitope selection may even allow gamma-herpesviruses contracted
from close relatives to establish higher average latent loads than
those from MHC class I-incompatible strangers. The data
presented here argue that small variations in key viral latency
genes can have major impacts on pathogenesis, and must therefore
be considered in any attempt to understand the infection of
individual hosts.
Materials and Methods
Cell culture and viruses
NIH-3T3-CRE cells [7] were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin. Baby hamster kidney cells (BHK-21) were cultured
in Glasgow’s modified Eagle’s medium supplemented as above
plus 10% tryptose phosphate broth. Murid gammaherpesvirus 4
(MuHV-4) strain 68 was used in this study [58]. To prepare viral
stocks, low multiplicity infections (0.001 PFU per cell) of NIH-
Figure 4. M284–92 epitope expression and CD8
+ T cells are
linked in setting splenic latent loads. BALB/c mice were
intranasally infected with the indicated viruses (10
4 PFU) and at 11,
13, 15, 17 and 19 days post-infection anti-CD8 monoclonal antibody
(MAb) was intraperitoneally injected. At 21 days post-infection spleens
were removed for analysis. Control mice are d21 infected littermates
that were not injected with MAb. A. Schematic diagram of the
experimental setting. B. Splenocytes were stained for CD8. The data
show the percentage of CD8
+ T cells of total lymphocytes (arithmetic
means6STDV) in depleted mice (black bars) and control mice (white
bars). C. Splenocytes were titrated for reactivation-competent virus by
explant co-culture. Each point shows the titre of one mouse. Black
symbols represent data for CD8
+ T cell depleted mice, white symbols
represent data for control mice. Horizontal lines indicate arithmetic
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PLoS Pathogens | www.plospathogens.org 6 October 2008 | Volume 4 | Issue 10 | e1000177Figure 5. Increased germinal center B cell colonization by MuHV-4 lacking M284–92 epitope anchor residues. BALB/c mice were
intranasally infected as shown and spleen sections hybridized with viral tRNA-specific riboprobes. A. Representative spleen sections from each group
of animals. Dark staining cells express viral tRNAs. Arrows indicate example positive cells. All sections are magnified 6200 and counter stained with
haematoxylin. B. Mean6SEM percentage of splenic follicles positive for viral tRNA expression. Six sections per mouse and three mice per group were
counted at each time point. Follicles were scored positive if they contained at least one viral tRNA positive cell. At d50 post-infection vM2F85A and
vM2L92A showed significantly higher latency loads than vWT (p=0.002 and p,0.001; using a 1 tailed Student’s t-Test), whereas vM2F85AEPI showed
no significant difference (p=0.45). C. BALB/c mice were intranasally infected with 10
4 PFU of the indicated virus. At 14 or 50 days post-infection,
reciprocal frequencies of viral infection in flow cytometrically purified germinal center (B220
+PNA
high) B cells were determined by limiting dilution and
real time PCR. Spleens were pooled from 5 mice per group. Bars show the frequency of viral DNA positive cells with 95% confidence intervals.
doi:10.1371/journal.ppat.1000177.g005
CD8
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by plaque assay [59].
Recombinant viruses
The vM2FS [36], vM2F85A, vM2L92A and vM2F85AEPI viruses
were derived from BAC-cloned MuHV-4 [60]. The M2F85A and
M2L92A mutations were generated by overlapping PCR: A4353G,
A4354C substituted alanine for phenylalanine at M2 position 85,
and A4332G, A4333C substituted alanine for leucine at position 92.
Mutated genomic fragments were inserted into a HinDIII-E
genomic clone [61] cloned in pST76K-SR shuttle plasmid [60]
using BlnI (nt 3908) and XhoI (nt 5362) restriction sites. To
generate vM2F85AEPI, a genomic HinDIII/XhoI fragment (nt
4029–5362) was PCR-amplified from an M2F85A template and
cloned into pSP72 (Promega). Genomic co-ordinates 3846–4029
were then amplified, using the primer 59-AAAAAGCTTAGGG-
GATTCAATAAACTTAAGTCGACGTTATAACAGTGAAG-
GTGCTAACGCAGAA-39 and cloned into the same vector as a
BglII/HindIII fragment, thereby attaching the amino acid
residues KLRGFNKLRSTL to the M2F85A C-terminus. This
construct was again subcloned into the HinDIII-E shuttle plasmid
using BlnI/XhoI restriction sites. A vM2F85A revertant virus
(vM2F85AR) was generated using a wild-type HinDIII-E genomic
clone. All PCR-derived regions were sequenced to confirm the
integrity of the mutations. Each HinDIII-E shuttle plasmid was
transformed into DH10B E.coli containing the wild type MuHV-4
BAC. Following recombination, mutated BAC clones were
identified by DNA sequencing. The integrity of each BAC was
confirmed by restriction digestion with BamHI and EcoRI. All
viruses were reconstituted by transfecting BAC DNA into BHK-21
cells using FuGENE 6 (Roche Molecular Biochemicals). The loxP-
flanked BAC cassette was then removed by viral passage through
NIH-3T3-CRE cells. The integrity of each reconstituted virus was
checked by PCR of viral DNA across the HinDIII-E region. The
stability of the introduced mutations was confirmed by viral DNA
sequencing across M2, both prior to infection and using viruses
recovered from infected mice.
In vivo infections and virus assays
6- to 8-week old BALB/c, C57BL/6, DBA/2, FVB-N (Instituto
Gulbenkian de Cie ˆncia, Portugal) and B6.C.H2
d mice (kindly
provided by C. Penha-Gonc ¸alves, Instituto Gulbenkian de
Cie ˆncia, Portugal) were inoculated intranasally with 10
4 PFU of
MuHV-4 under isofluorane anaesthesia. At different days post-
infection, lungs or spleens were removed for post-mortem analysis.
Titres of infectious virus were determined by plaque assay of
freeze-thawed tissue homogenates on BHK-21 cells. Latent virus
loads were quantified by explant co-culture of freshly isolated
Figure 6. MuHV-4 lacking the H2-K
d-restricted M2 CD8
+ T cell epitope is positively selected in a H2
d host. BALB/c or C57BL/6 mice were
intranasally infected with equal amounts of the indicated viruses, 10
4 PFU in total. At 14, 21 or 50 days post-infection germinal centre (B220
+PNA
high)
B cells were recovered from pools of al least three spleens by flow cytometric sorting. The copy number of each viral genome was then measured by
quantitative PCR using primers specific for each viral genome. Each sample was assayed in triplicate. Black bars denote the percentage of M2F85A or
vM2F85AEPI genomes in the total genome load. Error bars show 95% confidence intervals.
doi:10.1371/journal.ppat.1000177.g006
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assays) or 5 (explant co-culture assays) days, then fixed with 4%
formal saline and counterstained with toluidine blue for plaque
counting.
CD8
+ T cell depletions
MuHV-4 infected BALB/c mice were depleted of CD8
+ T cells
by 5 intraperitoneal injections of 200 mg of monoclonal antibody
YTS 169.4 [62]. Blood samples or splenocytes from depleted or
control mice were stained with APC-conjugated anti-CD8a and
phycoerythrin-conjugated anti-CD4 (BD Pharmingen) and ana-
lysed on a FCAScan Flow Cytometer using CellQuest software
(Becton Dickinson Immunocytometry systems).
In vitro T cell stimulation
Spleen cells (1–2610
6) were stimulated (6 h, 37uC) with 1 mM
GFNKLRSTL (M284–92) or HYLSTQSAL (EGFP200–208) pep-
tides (SIGMA-Genosys, Haverhill, UK) in RPMI supplemented
with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml
penicillin, 100 mg/ml streptomycin, 50 mM 2-mercaptoethanol,
10 U/ml recombinant murine IL-2 (PeproTech, UK) and 10 mg/
ml Brefeldin A. The cells were then washed in PBS/10 mg/ml
Brefeldin A, blocked with anti-CD16/32 mAb, stained with APC-
conjugated anti-CD8a (BD Pharmingen), washed twice, fixed in
2% paraformaldehyde (30 min, 4uC), washed once, permeabilized
with 0.5% saponin, washed once, stained with a phycoerythrin-
conjugated anti-interferon-gamma mAb (BD Pharmingen) and
washed twice. All cells were analysed on a BD FACSCanto Flow
Cytometer using FACSDiva software (BD Biosciences).
Limiting Dilution analysis
The frequency of MuHV-4 genome-positive germinal centre B
cells was determined by limiting dilution and real-time PCR [37]:
B220
+PNA
high B cells were recovered from pools of five spleens using
a BD FACSAria Flow Cytometer (BD Biosciences) and serially two
fold diluted. Eight replicates of each dilution were analysed by real
time PCR (ABI Prism 7000 Sequence Detection System, Applied
Biosystems). The primer/probe sets were specific for the MuHV-4
ORF65 gene (59 primer: GCCACGGTGGCCCTCTA; 39 primer:
CAGGCCTCCCTCCCTTTG; probe: 6-FAM-CTTCTGTTG-
ATCTTCC–MGB). Samples were subjected to a melting step of
95uC for 10 min followed by 40 cycles of 15 s at 95uCa n d1m i na t
60uC. Real-time PCR data was analysed on the ABI Prism 7000
software. The purity of sorted cells was always greater than 97.5%.
In situ hybridization
In situ hybridization with a digoxigenin-labelled riboprobe
encompassing MuHV-4 vtRNAs 1–4 and microRNAs 1–6 was
performed on formalin-fixed, paraffin-embedded spleen sections
[46]. Probes were generated by T7 transcription of a pEH1.4
(Roche Molecular Biochemicals). Positive follicles were scored
using a Leica DM 5000B microscope.
Viral genome quantification
Splenic germinal centre B cells (B220
+PNA
high)w e r eo b t a i n e d
from pools of three spleens using a BD FACSAria Flow Cytometer
(BD Biosciences) and lysed overnight in 0.45% Tween-20, 0.45%
NP-40, 2 mM MgCl2,5 0m MK C l ,1 0m MT r i s - H C lp H=8 . 3a n d
0.5 mg/ml Proteinase K. Individual viral genomes (vM2F85A/vWT;
vM2F85A/vM2L92A;v M 2 F85A/vM2F85AEPI or vM2F85AEPI/vWT)
were quantified by real time PCR (RotorGene 6000 5-plex HRM,
Corbett Research), using a labeled probe specific for M2 and a
common primer plus mutant-specific primer. vM2F85A/vWT viral
mix: probe- 6-FAM-CATGGGGACTTTAACGTCGACC-
TAAGTT-TMR; common primer-GGTTAACTTCTTCAG-
GACTTGGTACA; M2F85A specific primer-TCCTAAAACCA-
TAAGAAGGGGAGC; WT specific primer-TTTCCTAAAAC-





vM2F85A/vM2F85AEPI or vM2F85AEPI/vWT viral mixes: probe- 6-
FAM-CCCCATGAACCCTGAGATACGTCTTCCT-TMR;
common primer-TGGCTCGACTGACAGTCCAGA; M2F85A and
WT specific primer ACCTAAGTTTATTGAATCCCCTAAGC;
M2F85AEPI specific primer-GTCGACCTAAGTTTATT-
GAATCCCCT (all primers and probes from TIBMolbiol). Samples
were subjected to a melting step of 95uC, 5 min followed by 45 cycles
of 15 s at 95uCa n d4 5sa t6 5 uC. The wild-type, M2F85A,M 2 L92A or
M2F85AEPI HinDIII-E shuttle plasmids were used as templates to
derive standard curves. Real-time PCR data was analysed using
Rotor-Gene 6000 Series Software.
Statistical analysis
Data comparisons between different infection groups were
performed using Student’s t-Test, Friedman’s Test or the Kruskal-
Wallis Test as appropriate. For limiting dilution analysis 95%
confidence intervals were determined as previously described [36].
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